Impact of autoimmune phenomena on the clinical presentation and prognosis of Wilson’s disease: a retrospective cohort study
Metabolism and Target Organ Damage · 26.02.2026 · 6 (1)
DOI: 10.20517/mtod.2025.191 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Metabolism and Target Organ Damage, online erschienen am 26.02.2026. Verfasst von Hui Jiang und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Aim
To investigate the clinical relevance of autoimmune phenomena (AP), including autoantibody positivity and elevated serum immunoglobulins, in patients with Wilson’s disease (WD), particularly with respect to disease severity and prognosis.
Methods
We retrospectively enrolled treatment-naïve WD patients (Leipzig score ≥ 4) and classified them as WD with AP (AP-WD) or WD without AP (NAP-WD) based on autoantibody positivity (titer ≥ 1:100) and/or immunoglobulin G (IgG) above the upper limit of normal. Baseline laboratory data, clinical complications, and liver histopathology were compared. Patients received standard anti-copper therapy and were followed longitudinally to evaluate the impact of AP on liver-related outcomes.
Results
Eighty-six treatment-naïve WD patients were included (48 AP-WD, 38 NAP-WD). At baseline, AP-WD patients exhibited more severe laboratory and clinical features, including lower platelet counts, reduced albumin, prolonged international normalized ratio, higher aspartate aminotransferase-to-platelet ratio index (APRI), Model for End-Stage Liver Disease (MELD)/Pediatric End-Stage Liver Disease (PELD), and Child-Pugh scores, and greater prevalence of ascites (all P < 0.05). Histopathological analysis demonstrated increased plasma cell infiltration and heightened portal inflammatory activity in the AP-WD group (P < 0.05). Longitudinal follow-up revealed that the presence of AP was independently associated with an increased risk of adverse liver-related events, including liver transplantation, or death.
Conclusion
AP is common in WD and correlates with more severe hepatic dysfunction and poorer long-term outcomes. Screening for autoantibodies and IgG levels in newly diagnosed WD patients may provide important prognostic insight and facilitate early risk stratification, guiding tailored monitoring and management strategies.
Zitieren
APA
Jiang, H., Tang, S., Liang, C., Liu, H., Yu, H., Zhang, S., Li, M., Wang, Y., Hou, W., & Zheng, S. (2026). Impact of autoimmune phenomena on the clinical presentation and prognosis of Wilson’s disease: a retrospective cohort study. Metabolism and Target Organ Damage, 6(1). https://doi.org/10.20517/mtod.2025.191
Vancouver
Jiang H, Tang S, Liang C, Liu H, Yu H, Zhang S, et al. Impact of autoimmune phenomena on the clinical presentation and prognosis of Wilson’s disease: a retrospective cohort study. Metabolism and Target Organ Damage. 2026;6(1). doi:10.20517/mtod.2025.191
BibTeX
@article{Jiang2026,
author = {Jiang, Hui and Tang, Shan and Liang, Chen and Liu, Hui and Yu, Haitian and Zhang, Siqi and Li, Meihan and Wang, Yue and Hou, Wei and Zheng, Sujun},
title = {Impact of autoimmune phenomena on the clinical presentation and prognosis of Wilson’s disease: a retrospective cohort study},
journal = {Metabolism and Target Organ Damage},
year = {2026},
volume = {6},
number = {1},
doi = {10.20517/mtod.2025.191}
}
EUVIMED